Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 1,563 | 3,570 | 2,657 | 410 | 2,966 |
| Cost of Goods | N/A | N/A | N/A | N/A | 128 |
| Gross Profit | 1,563 | 3,570 | 2,657 | 410 | 2,838 |
| Operating Expenses | 2,777 | 4,328 | 3,382 | 4,325 | 8,191 |
| Operating Income | -1,214 | -758 | -725 | -3,915 | -5,225 |
| Interest Expense | 200 | 450 | 449 | 223 | 592 |
| Other Income | 535 | 0 | -2,600 | 296 | 0 |
| Pre-tax Income | -879 | -1,208 | -3,774 | -3,842 | -5,817 |
| Income Tax | N/A | N/A | N/A | -3,842 | -135 |
| Net Income Continuous | -879 | -1,208 | -3,774 | 0 | -5,682 |
| Net Income | $-879 | $-1,208 | $-3,774 | $0 | $-5,682 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.14 | -0.18 | -0.36 |
| EPS Basic Continuous Ops | -0.02 | -0.04 | -0.14 | 0.00 | -0.36 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.14 | -0.18 | -0.36 |
| EPS Diluted Continuous Ops | -0.02 | -0.04 | -0.14 | 0.00 | -0.36 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.04 | -0.14 | -0.18 | -0.36 |
| EBITDA(a) | $-1,124 | $-633 | $-386 | $-3,548 | $-4,832 |